Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Operating Leases (2021 - 2025)

AdaptHealth has reported Operating Leases over the past 5 years, most recently at $85.5 million for Q4 2025.

  • Quarterly results put Operating Leases at $85.5 million for Q4 2025, up 6.47% from a year ago — trailing twelve months through Dec 2025 was $85.5 million (up 6.47% YoY), and the annual figure for FY2025 was $85.5 million, up 6.47%.
  • Operating Leases for Q4 2025 was $85.5 million at AdaptHealth, up from $77.2 million in the prior quarter.
  • Over the last five years, Operating Leases for AHCO hit a ceiling of $151.6 million in Q4 2021 and a floor of $77.2 million in Q3 2025.
  • Median Operating Leases over the past 5 years was $103.7 million (2022), compared with a mean of $102.8 million.
  • Biggest five-year swings in Operating Leases: tumbled 31.14% in 2022 and later grew 28.83% in 2024.
  • AdaptHealth's Operating Leases stood at $151.6 million in 2021, then tumbled by 31.14% to $104.4 million in 2022, then dropped by 18.07% to $85.5 million in 2023, then decreased by 6.14% to $80.3 million in 2024, then increased by 6.47% to $85.5 million in 2025.
  • The last three reported values for Operating Leases were $85.5 million (Q4 2025), $77.2 million (Q3 2025), and $100.4 million (Q2 2025) per Business Quant data.